GALECTIN THERAPEUTICS INC 4
4 · GALECTIN THERAPEUTICS INC · Filed Jul 8, 2015
Insider Transaction Report
Form 4
MAULDIN JOHN F
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2015-04-08−14,815→ 0 totalExercise: $8.10Exp: 2021-06-02→ Common Stock (14,815 underlying) - Award
Common Stock
2015-04-08+25,483→ 42,669 total - Award
Common Stock
2015-03-12+11,112→ 17,186 total - Disposition to Issuer
Stock Option (right to buy)
2015-04-08−16,714→ 0 totalExercise: $3.59Exp: 2023-03-28→ Common Stock (16,714 underlying)
Holdings
- 4,947(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The option vested quarterly in eight equal installments beginning September 2, 2011.
- [F2]The option was canceled by mutual agreement of the reporting person and Galectin Therapeutics, Inc. The reporting person received 25,483 shares of restricted common stock, reported in Table 1 of this Form 4, as consideration for the cancellation of options granted on June 2, 2011 and March 28, 2013.
- [F3]The option vested quarterly in eight equal installments beginning on May 12, 2013.